LONDON (Alliance News) - Collagen Solutions PLC said Tuesday that it had signed an exclusive license for intellectual property for a process to produce collagen-based 'tissues.'
The IP was developed in Robert Brown's laboratory at the University College London, and a core patent for the technology has already been granted in the US. It expects to use the licence to produce new collagen-based tissue replacements.
The 'tissues' created via the process are stronger and more durable, the company said, and can be used to replace skin, tendon, bone, cartilage, blood vessels and nerve conduits.
The company said that the advantage of the products to natural materials are their strength and rapid production time.
"The licensing of this IP is designed to integrate our specialist collagen capabilities with the diverse biomedical capacity and global research standing of UCL and will drive forward patient benefit in many new areas of regenerative medicine," said Chief Executive Stewart White in a statement.
No financial details if the deal were disclosed.
Shares in Collagen Solutions were trading down 0.8% at 9.05 pence Tuesday morning.
By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews
Copyright 2014 Alliance News Limited. All Rights Reserved.